Tag: FDA
Browse our exclusive articles!
US FDA Approves Bladder Cancer Treatment Inlexzo from J&J
The U.S. Food and Drug Administration has granted approval to Johnson & Johnson’s drug delivery system for a specific type of bladder cancer. The...
FDA Approves Recombinant VWF Treatment in Pediatric Patients
The US Food and Drug Administration (FDA) has expanded the indication for recombinant von Willebrand factor (VWF), marketed as Vonvendi, to include children with...
FDA Approves Eisai’s Leqembi IQLIK for Alzheimer’s Treatment
Eisai has achieved an important regulatory milestone as the FDA approves Leqembi IQLIK, strengthening the company’s long-term plans to expand the medicine’s use in...
FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia
The US FDA approves Sanofi’s Wayrilz (rilzabrutinib) for use in adult patients with chronic or persistent immune thrombocytopenia (ITP) who did not respond adequately...
U.S. FDA Approves Ionis’ DAWNZERA for Hereditary Angioedema
Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted approval for DAWNZERA™ (donidalorsen). The treatment is approved for prophylaxis to...
